-
EP0750608
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0750608
| EP0750608 - PHARMACEUTICAL PRODUCT COMPRISING A SALICYLATE OF AN ESTERIFIABLE BETA-BLOCKER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.07.1998 Database last updated on 22.08.2024 | Most recent event Tooltip | 24.07.1998 | Application deemed to be withdrawn | published on 09.09.1998 [1998/37] | Applicant(s) | For all designated states CAL INTERNATIONAL LIMITED 15 Butterfield Park Rathfarnham Dublin 14 / IE | [1997/01] | Inventor(s) | 01 /
BYRNE, William 6 Mather Road North Mount Merrion County Dublin / IE | 02 /
RYNNE, Andrew 2 Liffey Lawns Clane County Kildare / IE | [1997/01] | Representative(s) | O'Brien, John Augustine, et al John A. O'Brien & Associates Unit 4, The Courtyard Business Centre Orchard Lane Blackrock, County Dublin, A94 NV07 / IE | [N/P] |
| Former [1998/07] | O'Brien, John Augustine, et al John A. O'Brien & Associates, Third Floor, Duncairn House, 14 Carysfort Avenue Blackrock, Co Dublin / IE | ||
| Former [1997/01] | O'Brien, John Augustine, et al Cruickshank & Co. 1 Holles Street Dublin 2 / IE | Application number, filing date | 95908363.5 | 27.01.1995 | [1997/01] | WO1995IE00011 | Priority number, date | IE19940000079 | 28.01.1994 Original published format: IE 940079 | [1997/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9520568 | Date: | 03.08.1995 | Language: | EN | [1995/33] | Type: | A1 Application with search report | No.: | EP0750608 | Date: | 02.01.1997 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.08.1995 takes the place of the publication of the European patent application. | [1997/01] | Search report(s) | International search report - published on: | EP | 03.08.1995 | Classification | IPC: | C07C235/34, C07C219/14, C07D209/08, C07D285/10, A61K31/60 | [1997/01] | CPC: |
C07D209/08 (EP);
A61K31/60 (EP);
A61P25/02 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07C219/14 (EP);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/01] | Title | German: | PHARMAZEUTISCHES PRODUKT, WELCHES EIN SALICYLAT EINES VERESTERBAREN BETA-BLOCKERS ENTHÄLT | [1997/01] | English: | PHARMACEUTICAL PRODUCT COMPRISING A SALICYLATE OF AN ESTERIFIABLE BETA-BLOCKER | [1997/01] | French: | PRODUIT PHARMACEUTIQUE COMPORTANT UN SALICYLATE D'UN AGENT BETA-BLOQUANT ESTERIFIABLE | [1997/01] | Entry into regional phase | 31.07.1996 | National basic fee paid | 31.07.1996 | Designation fee(s) paid | 31.07.1996 | Examination fee paid | Examination procedure | 28.06.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 05.08.1996 | Examination requested [1997/01] | 27.10.1997 | Despatch of a communication from the examining division (Time limit: M04) | 07.03.1998 | Application deemed to be withdrawn, date of legal effect [1998/37] | 03.04.1998 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1998/37] | Fees paid | Renewal fee | 12.11.1996 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.01.1998 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO8807044 (INSITE VISION INC [US]) [X] 1,3,11-16,19-21,28,30,33-35,37 * page 7, line 5 - page 8, line 12 * * page 3, line 18 - line 20; examples XVII,XX; claims 1,32 *; | [X]DE2635209 (SANDOZ AG) [X] 1,3,12,33-35 * page 3, line 21 - page 4, line 4; example 1H *; | [A]EP0449426 (INT MEDICAL RESEARCH LIMITED [IE]) [A] 1,4,34 * page 2, line 26 - line 27; claim - * |